期刊文献+

膀胱肿瘤中错配修复基因hMLH1启动子甲基化状态的研究 被引量:4

Study of promoter methylation of mismatch repair gene hMLH1 in bladder neoplasms
原文传递
导出
摘要 目的探讨膀胱肿瘤中错配修复基因hMLH1启动子甲基化状态及其意义。方法收集30对新鲜的膀胱癌组织及其癌周正常组织;采用甲基化特异聚合酶链反应(methylationspecificPCR,MSP)检测hMLH1基因启动子区CpG岛的甲基化状态。结果30对膀胱癌组织、癌周正常组织中hMLH1基因的甲基化阳性率分别为10/30、1/30,二者差异有统计学意义(P<0.01);hMLH1基因甲基化阳性率在Ta~T1期、T2~T3期膀胱癌中分别为7/19、3/11,二者差异无统计学意义(P>0.05);在Ⅰ、Ⅱ、Ⅲ级膀胱癌中分别为7/18、2/9、1/3,三者差异无统计学意义(P>0.05)。结论错配修复基因hMLH1在膀胱癌组织中有一定程度的过甲基化,但与膀胱癌的临床病理特点无显著相关性,提示hMLH1的异常甲基化可能参与了膀胱肿瘤的发生。 Objective To explore the methylation status of mismatch repair gene hMLH1 in bladder cancer and its meaning. Methods Thirty fresh bladder tumor tissues and paired adjacent normal tissues were obtained from cystectomy specimens. The CpG island methylation status of hMLH1 was examined by means of methylation specific PCR (MSP). Results hMLH1 methylation was present in 10 of 30 tumor tissues and in 1 of 30 normal tissues ; there was significant difference between them( P 〈 0.01 ). The positive rates of hMLH1 methylation in stage Ta - T1 and T2 - T3 bladder cancer were 7 of 19 and 3 of 11,respectively; there was no significant difference between them (P 〉 0.05 ). The positive rates in grade Ⅰ,Ⅱ and Ⅲ bladder cancer were 7 of 18, 2 of 9 and 1 of 3, respectively; there was no significant difference among them( P 〉 0. 05 ). Conclusion There exists a certain degree of hMLH1 methylation in bladder cancer, but it does not correlate with stage and grade of bladder cancer, suggesting that the aberrant methylation of hMLH1 may be involved in the tumorigenesis of bladder neoplasams.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第7期736-738,共3页 Chinese Journal of Laboratory Medicine
  • 相关文献

参考文献9

  • 1Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, brighter future. Oncogene, 2002, 21:5427 -5440.
  • 2Gu L, Wu J, Zhu BB, et al. Deficiency of a novel mismatch repair activity in a bladder tumor cell line. Nucleic Acids Res ,2002, 30:2758-2763.
  • 3Murata H, Khattar NH, Kang Y, et al. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene,2002,21:5696-5703.
  • 4Deng G, Peng E, Gum J, et al. Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer. Br J Cancer, 2002,86:574-579.
  • 5Bevilacqua RA, Simpson AJ. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with highlevel microsatellite instability. Int J Cancer,2000,87:200-203.
  • 6Esteller M, Catasus L, Matias-Guiu X, et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol, 1999,155 : 1767-1772.
  • 7Geisler JP, Goodheart MJ, Sood AK, et al. Mismatch repair gene xpression defects contribute to microsatellite instability in ovarian carcinoma. Cancer, 2003,98:2199-2206.
  • 8Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res,2001, 61 : 3225-3229.
  • 9Chan MW, Chart LW, Tang NL, et al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin Cancer Res ,2002 ,8:464-470.

同被引文献28

  • 1张剑英,李智,于永春,段建敏.膀胱癌和肾癌组织中RASSF1A基因的甲基化改变[J].中华泌尿外科杂志,2006,27(S1):9-11. 被引量:7
  • 2赵敏,李智,于永春,段建敏,李晶华.膀胱癌组织中上皮细胞钙依粘连蛋白基因启动子区CpG岛甲基化状态的分析[J].检验医学,2005,20(1):55-58. 被引量:6
  • 3Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, et al. Altered methylation of multiple genes in carcinogenesis of the prostate[J]. Int J Cancer 2003, 106: 382-387.
  • 4Kawamoto K, Okino S T, Place R F, Urakami S, Hirata H, Kikuno N, et al. Epigenetie modifications of RASSF1A gene through chromatin remodeling in prostate cancer [J]. Clin Cancer Res, 2007, 13: 2541-2548.
  • 5Esteller M, Corn P G, Urena J M, Gabrielson E, Baylin S B, Herman J G. Inactivation of glutathione S-transferase Pl gene by promoter hypermethylation in human neoplasia[J]. Cancer Res, 1998, 58:4515-4518.
  • 6Lo K W, Kwong J, Hui A B, Chan S Y, To K F, Chan A S, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma[J]. Cancer Res, 2001, 61: 77-3881.
  • 7Altimari A, Grigioni A D, Benedettini E, Gabusi E, Schiavina R, Martinelli A,et al. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer [J]. Am J Clin Pathol, 2008, 129:756-762.
  • 8Woodson K, O'Reilly K J, Hanson J C, Nelson D, Walk E L, Tangrea J A. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate eancer[J]. J Urol, 2008, 179:508-512.
  • 9Roupret M, Hupertan V, Catto J W, Yates D R, Rehman I, Proctor L M, et al. Promoter hypermethylation in circulating blood cells identifies prostate cancer progression [J]. Int J Cancer, 2008, 122:952-956.
  • 10Aitehison A, Warren A, Neal D, Rabbitts P. RASSF1A promoter methylation is frequently detected in both pre-malignant and non-malignant microdisseeted prostatic epithelial tissues [J]. Prostate, 2007, 67:638-644.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部